Related Experiment Video
Updated: Jul 5, 2026
07:36
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
[Analgesic activity of dipeptide Tyr-Pro]
Izvestiia Akademii Nauk. Seriia Biologicheskaia
|May 22, 2008
Summary
The dipeptide Tyr-Pro and its analogs, Tyr-Pro-NH2 and Tyr-Pro-OMe, reduced pain sensitivity across multiple tests. Naloxone partially blocked these analgesic effects, suggesting opioid involvement.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Research
Context:
- Opioid peptides are crucial in pain modulation.
- Dipeptides like Tyr-Pro are found in various opioid peptides.
- Understanding the analgesic properties of opioid peptide fragments is important for pain management.
Purpose:
- To investigate the analgesic activity of the dipeptide Tyr-Pro and its analogs.
- To evaluate the influence of Tyr-Pro and its derivatives on different pain sensitivity tests.
- To explore the potential opioid receptor involvement in the observed effects.
Summary:
- Intraperitoneal administration of Tyr-Pro decreased pain thresholds in tail-flick, tail pinch, formalin, and acetic acid writing tests.
- The analogs Tyr-Pro-NH2 and Tyr-Pro-OMe exhibited similar analgesic activity in the tail-flick test and enhanced activity in the acetic acid writing test.
- Coadministration with naloxone or naloxone methiodide showed a minor reduction in the analgesic effect, indicating partial opioid receptor interaction.
Impact:
- This study elucidates the direct analgesic potential of the Tyr-Pro dipeptide and its synthetic analogs.
- Findings suggest that Tyr-Pro derivatives could be explored as novel therapeutic agents for pain relief.
- The research contributes to understanding the structure-activity relationships of opioid peptide fragments in pain modulation.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:30Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...